Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

New and experimental HIV treatments news

Show

From To
Harmless virus slows HIV progression by stimulating chemokine release

A harmless hepatitis virus slows the progression of HIV by stimulating the release of chemokines, according to a study presented in the June 19th edition

Published
18 June 2004
By
Christopher Gadd
Dietary supplements can improve diarrhoea and increase antiretroviral drug levels in AIDS patients

Supplements containing glutamine or alanyl-glutamine can improve the diarrhoea and reduced absorption of antiretroviral drugs seen in AIDS patients, according to a Brazilian study published

Published
08 June 2004
By
Christopher Gadd
Gilead, Merck, BMS plan fixed dose combination

A fixed dose combination of three branded antiretrovirals could be on the market within 18 months if manufacturers can solve co-formulation problems, following an announcement

Published
17 May 2004
By
Keith Alcorn
FTC price agreement will allow first-line use in London

London HIV clinics will be permitted to prescribe the new antiretroviral FTC (emtricitabine, Emtriva ) following an agreement last month between its manufacturer Gilead and

Published
14 May 2004
By
Keith Alcorn
Prednisolone delays CD4 T-cell decreases in chronic HIV infection

The glucocorticoid drug prednisolone can delay the depletion of CD4 T-cells in HIV-positive people, according to a retrospective study published on 5 May 2004 in

Published
07 May 2004
By
Christopher Gadd
Can a sugar cane drink effectively treat mitochondrial toxicity?

German researchers report the success of an oral sugar cane supplement, mitocnol, in rapidly reversing signs of NRTI-induced life-threatening mitochondrial toxicity, according to a letter

Published
06 May 2004
By
Edwin J. Bernard
Prodrug of tenofovir works well in the presence of some NRTI resistance

Treatment-experienced individuals who have one or two thymidine analogue-associated resistance mutations still experience a significant reduction in HIV viral load if treated with tenofovir disoproxil

Published
02 May 2004
By
Michael Carter
Canadian company reports promising lipodystrophy treatment

A Canadian company, Theratechnologies, believes it may have developed a treatment that can reduce the abdominal fat accumulation seen in HIV-positive people who develop lipodystrophy.

Published
19 April 2004
By
Keith Alcorn
Four year follow-up shows Kaletra to be safe, effective, durable

Lopinavir/ritonavir (KaletraTM) has a potent and durable anti-HIV effect when used in combination with d4T and 3TC, and a good side-effect profile, according to a

Published
05 April 2004
By
Michael Carter
New-Fill recommended for approval in US as Sculptra (amended)

Five years after its European approval, last week the FDA's General & Plastic Surgery Devices Advisory Panel finally recommended for approval poly-L-lactic acid for the treatment

Published
02 April 2004
By
Edwin J. Bernard

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.